1
Stimulant detox is the medical clearance — stimulant rehab is the reward-system rebuild. The crash ends in 5 to 14 days. The dopamine recalibration takes weeks to months. That gap is where residential stimulant rehab does its actual work, and clients discharged before the gap closes are the ones who relapse fastest.
For stimulant use disorder specifically, contingency management is research-supported standard of care — small structured rewards (vouchers, privileges) for verifiable abstinence. The mechanism: it teaches the reward system to find pleasure in non-substance reinforcement again. We integrate contingency management from week one of stimulant rehab. Most competitor programs skip it or hedge; the clinical evidence is strong enough that we don’t.
Stimulant addiction treatment looks different from alcohol or opioid treatment. There’s no FDA-approved withdrawal medication for stimulants. The clinical work is mostly behavioral — and that’s why a long-enough residential stay matters more than for substances with MAT options. Anhedonia, the inability to feel pleasure, is the central post-acute symptom. It peaks in detox. It lifts gradually over 2 to 4 weeks of residential.
Cocaine has its own track. Methamphetamine has its own track — see our cocaine residential and meth residential pages for substance-specific protocols. Prescription stimulants (Adderall, Vyvanse, Ritalin) have their own track. Polysubstance cases — stimulants plus alcohol, opioids, or benzos — run across all three with coordinated MAT planning where applicable.
We’ve found that the clients who do best in stimulant rehab are the ones who stop expecting it to feel like alcohol or opioid recovery. Different mechanism. Different timeline.
Resort-Style Pool
Spa, Sauna & Wellness Suite
Chef-Prepared Meals DailyContingency management is a research-supported behavioral treatment for stimulant addiction. The framework: small structured rewards — vouchers, privileges, recognition — for verifiable abstinence (typically confirmed by urine testing). The mechanism: it teaches the dopamine reward system to find pleasure in non-substance reinforcement. Clinical evidence is strong, particularly for cocaine and methamphetamine use disorders where there’s no FDA-approved medication. We integrate contingency management from week one of stimulant rehab and continue it through aftercare when local outpatient programs offer it. Most stimulant addiction treatment programs skip contingency management or use it minimally; the evidence base supports doing it routinely.
Standard residential stimulant rehab runs 30 to 90 days. Cocaine cases often complete the core work in 30 to 60 days. Methamphetamine cases (see our meth residential page) typically need 60 to 90 days because the cognitive recovery arc is longer. Prescription stimulant cases — Adderall, Vyvanse, Ritalin — vary by dose and duration; some step down to outpatient at 30 days when ADHD reassessment is clean. The reward-system rebuild benefits from at least 60 days of structured stimulant addiction recovery work for most cases. Insurance covers 30 days as a baseline; longer stays require medical-necessity documentation, which we prepare.
Adderall addiction treatment overlaps significantly with cocaine and meth rehab on the reward-system rebuild but differs on diagnostic context. Many Adderall cases involve underlying ADHD that needs continued treatment — sometimes with non-stimulant alternatives (atomoxetine, guanfacine). The ADHD reassessment piece distinguishes prescription-stimulant cases from illicit-stimulant cases. Vyvanse and Ritalin follow similar patterns. Withdrawal severity is typically lower than for cocaine or methamphetamine, but the behavioral work — relapse prevention, contingency management, trauma processing — is the same. See our ADHD treatment page for the dual-diagnosis pathway.
Most major commercial insurers cover residential stimulant rehab under SUD parity laws. Coverage commonly extends to Anthem Blue Cross, Aetna, Cigna, Carelon Behavioral Health, Optum Behavioral Health, and Magellan Health. The lack of FDA-approved medications for stimulant use disorder means medical-necessity documentation focuses on behavioral severity, polysubstance use, and dual-diagnosis presentations — our admissions team prepares the documentation to support 60 to 90 day length-of-stay when warranted. Same-day insurance verification is standard at GEVS. To start, see our verify your insurance page or call (844) 501-5005.